MedTrace Logo

HyperArc Registry Study

NCT05270707 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 968

Last updated 2025-09-24

No results posted yet for this study

Summary

The HyperArc registry is designed to collect data from which the efficacy of the HyperArc procedure can be assessed and compared to alternative treatments.

Conditions

Interventions

RADIATION

Stereotactic radiosurgery

HyperArc is a radiotherapy treatment with a structured workflow to plan and deliver stereotactic radiosurgery (SRS).

Sponsors & Collaborators

  • Varian, a Siemens Healthineers Company

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-31
Primary Completion
2025-03-31
Completion
2025-03-31
FDA Device
Yes

Countries

  • United States
  • Australia
  • Belgium
  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05270707 on ClinicalTrials.gov